Proton Therapy Shown to be Less Costly Than Some Alternative Radiotherapy Techniques For Early Stage Breast Cancer
Findings may challenge assumption that proton therapy is more costly than other traditional treatments and supports case for insurance coverage
MD Anderson News Release 10/31/14
In terms of duration of treatment and cost, patients with early stage breast cancer may benefit from accelerated partial breast irradiation (APBI) with proton therapy versus whole breast irradiation (WBI), according to new research from The University...
In year two, MD Anderson Moon Shots Program begins to spin off innovation
New surgical approach, first-of-a-kind clinical trials, family outreach program debut
MD Anderson News Release 10/30/14
Improved...
Oxygen-deprived RNA molecules lead to tumor progression
MD Anderson study reports previously unknown effects on critical enzymes Drosha and Dicer
MD Anderson News Release 10/29/14
<...YEATS Protein Potential Therapeutic Target for Cancer
MD Anderson News Release 10/23/2014
Federal Express® and UPS® are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.
One area of interest focuses on histones, the chief component of chromatin, a cluster of large molecules. Aberrations in chromatin are thought to lead to DNA damage...
Cancer exosomes are 'micro factories' that aid in tumor growth
Tiny nano-sized particles may play a major role in detecting and tracking breast cancer
MD Anderson News Release 10/23/2014
<...Two faculty elected to Institute of Medicine
MD Anderson News Release 10/20/2014
“Two leaders at The University of Texas MD Anderson Cancer Center have been elected to the Institute...
MD Anderson study first to compare treatments, survival benefits for early-stage lung cancer
MD Anderson News Release 10/15/14
Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall...
Researchers reveal genomic diversity of individual lung tumors
Findings suggest sequencing a single region of a localized tumor will identify driver mutations
MD Anderson News Release 10/09/14
Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration
MD Anderson News Release 10/06/14
Bristol-Myers Squibb Company (NYSE: BMY) and The University of Texas MD Anderson Cancer Center today...
San Antonio A Conversation With a Living Legend® slates UT’s Mack Brown, A&M’s R.C. Slocum
Gridiron greats lend dual support of MD Anderson’s game plan to end cancer
MD Anderson News Release 10/06/14
Two of the greatest...